Main > RHEUMATOLOGY>RHEUMATOID ARTHRITIS > Treatment > RANK Ligand (RANKL). > RANKL MAb-Type Inhibitor > Co.: USA. A (Phase II/Patents)



Co.: USA. A (Phase II/Patents)'s subsections
Company
Generic Name: DenosuMAb
OsteoProtegerin
Patent
UpDate: 01.26.06

Co.: USA. A (Phase II/Patents)'s products
This section has no products